China SXT Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $16.1M | $15.6M |
| FY2023 | $117.9K | $14.7M | $17.4M |
| FY2024 | $117.1K | $13.9M | $12.1M |
| FY2025 | $96.3K | $15.4M | $18.1M |
| FY2026 | $644.4K | $29.7M | $28.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $16.1M | $15.6M |
| FY2023 | $117.9K | $14.7M | $17.4M |
| FY2024 | $117.1K | $13.9M | $12.1M |
| FY2025 | $96.3K | $15.4M | $18.1M |
| FY2026 | $644.4K | $29.7M | $28.2M |